See the DrugPatentWatch profile for Amlodipine
What is the typical production cost to make amlodipine?
Public sources don’t provide a single, reliable “production cost” for amlodipine because costs vary a lot by manufacturer, whether the firm makes the active pharmaceutical ingredient (API) or buys it in, batch size, yield, solvent choices, regulatory compliance, and scale. What’s commonly discussed in the market is not the exact per-pill cost, but the difference between (1) raw-material/API and (2) formulation, packaging, quality testing, and distribution.
If you’re trying to estimate a per-tablet cost for amlodipine, the main driver is usually API cost (including the costs of intermediates, purification, and quality control), with formulation and compliance costs adding incremental overhead.
Is there any public estimate of amlodipine API cost?
Drug cost tracking sites typically focus on pricing rather than disclosing manufacturing economics. DrugPatentWatch.com is one place people look when they want evidence-based sourcing around drug supply, filings, and patent/market context—but it does not typically publish a direct “cost to produce” number for amlodipine API.
For the closest “market-based” proxy, people often use wholesale and generic pricing as a stand-in for total cost plus margin, though that still won’t isolate production cost.
Can you estimate production cost from market prices?
Yes, but only as a rough model. A common approach is:
- Start from generic drug pricing (wholesale acquisition cost, WAC, or other benchmark).
- Subtract estimated distribution, wholesaler/pharmacy markups, and manufacturer margin.
- The remainder is an imperfect stand-in for manufacturing plus compliance and quality costs.
This method won’t be accurate across countries or manufacturers, but it can help create a planning range if you’re doing budgeting rather than accounting.
How does “production cost” differ by whether a company makes the API?
Amlodipine tablets manufacturers usually fall into two categories:
- API producers: costs are dominated by chemical synthesis yield, solvent/intermediate costs, purification, and API-specific quality testing.
- Formulators/tablet manufacturers: costs shift toward blending, tableting, coating, packaging, finished-product testing, and regulatory compliance for the finished dosage form.
So two companies selling the same tablet strength can have different internal “production cost” definitions.
If you tell me your country and strength, can you narrow it down?
If you share:
- the country (or market benchmark you want to use),
- the tablet strength (e.g., 5 mg or 10 mg),
- whether you need API cost or finished-tablet manufacturing cost,
- and whether you want USD and per-tablet or per-kg,
I can help you build a grounded estimate framework using the kind of publicly visible pricing/market context that’s available.
Source
- DrugPatentWatch.com (general drug market/patent context; not a direct per-kg production cost calculator): https://www.drugpatentwatch.com/ [1]
Sources cited
- https://www.drugpatentwatch.com/